SAGE Therapeutics

sagerx.com

Sage Therapeutics is a biopharmaceutical company focused on pioneering solutions for brain health disorders, particularly maternal mental health. They are known for their FDA-approved treatments for postpartum depression, including ZURZUVAE® and ZULRESSO®. Their innovative approach integrates patient perspectives into research and commercialization, aiming to impact millions of lives. With a strong commitment to addressing a wide range of brain health disorders, Sage Therapeutics is positioned as a leader in the biopharmaceutical industry, leveraging cutting-edge science and strong partnerships to drive their mission forward.